Literature DB >> 23720796

Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems.

Toshie Harino1, Shizuo Kayama, Ryuichi Kuwahara, Seiya Kashiyama, Norifumi Shigemoto, Makoto Onodera, Michiya Yokozaki, Hiroki Ohge, Motoyuki Sugai.   

Abstract

Klebsiella pneumoniae showing high resistance to all β-lactams except imipenem, designated as ISMRK (imipenem-susceptible meropenem-resistant Klebsiella) is emerging in Japan. The carbapenem resistance of ISMRK cannot be screened by the Vitek and the RAISUS rapid automated susceptibility test systems, which may lead to inappropriate antimicrobial therapy, resulting in compromised patient outcomes.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23720796      PMCID： PMC3719643          DOI： 10.1128/JCM.02649-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.

Authors:  Norifumi Shigemoto; Ryuichi Kuwahara; Shizuo Kayama; Wataru Shimizu; Makoto Onodera; Michiya Yokozaki; Junzo Hisatsune; Fuminori Kato; Hiroki Ohge; Motoyuki Sugai
Journal:  Diagn Microbiol Infect Dis       Date:  2011-11-10       Impact factor: 2.803

2.  Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae.

Authors:  Neil Woodford; Anne T Eastaway; Michael Ford; Alistair Leanord; Chloe Keane; Reinhard M Quayle; Jane A Steer; Jiancheng Zhang; David M Livermore
Journal:  J Clin Microbiol       Date:  2010-06-09       Impact factor: 5.948

Review 3.  Antimicrobial susceptibility testing: a review of general principles and contemporary practices.

Authors:  James H Jorgensen; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

4.  Assessment of RAISUS, a novel system for identification and antimicrobial susceptibility testing for enterococci.

Authors:  Keiji Kanemitsu; Hiroyuki Kunishima; Ken Inden; Masamitsu Hatta; Tomoo Saga; Kumi Ueno; Hideo Harigae; Kenichi Ishizawa; Mitsuo Kaku
Journal:  Diagn Microbiol Infect Dis       Date:  2005-09       Impact factor: 2.803

5.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.

Authors:  J Barenfanger; C Drake; G Kacich
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 6.  Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.

Authors:  Elizabeth B Hirsch; Vincent H Tam
Journal:  J Antimicrob Chemother       Date:  2010-04-08       Impact factor: 5.790

7.  Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection.

Authors:  Simona Bratu; Mohamad Mooty; Satyen Nichani; David Landman; Carl Gullans; Barbara Pettinato; Usha Karumudi; Pooja Tolaney; John Quale
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

8.  Clinical impact of rapid in vitro susceptibility testing and bacterial identification.

Authors:  G V Doern; R Vautour; M Gaudet; B Levy
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

9.  Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.

Authors:  K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

10.  Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.

Authors:  Fred C Tenover; Rajinder K Kalsi; Portia P Williams; Roberta B Carey; Sheila Stocker; David Lonsway; J Kamile Rasheed; James W Biddle; John E McGowan; Bruce Hanna
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883
  10 in total
  7 in total

1.  Evaluation of the vitek 2 AST-N269 card for detection of meropenem resistance in imipenem-susceptible meropenem-resistant Enterobacteriaceae.

Authors:  Akira Koizumi; Kei Kasahara; Yuko Komatsu; Koji Ui; Fumiko Mizuno; Akifumi Nakayama; Keiichi Mikasa
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

2.  Complete nucleotide sequence of the IncN plasmid encoding IMP-6 and CTX-M-2 from emerging carbapenem-resistant Enterobacteriaceae in Japan.

Authors:  Shizuo Kayama; Norifumi Shigemoto; Ryuichi Kuwahara; Kenshiro Oshima; Hideki Hirakawa; Junzo Hisatsune; Thomas Jové; Hisaaki Nishio; Katsutoshi Yamasaki; Yasunao Wada; Takeshi Ueshimo; Tetsuya Miura; Taijiro Sueda; Makoto Onodera; Michiya Yokozaki; Masahira Hattori; Hiroki Ohge; Motoyuki Sugai
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

3.  Suitability of Carbapenem Inactivation Method (CIM) for Detection of IMP Metallo-β-Lactamase-Producing Enterobacteriaceae.

Authors:  Kyoichi Saito; Ryuichi Nakano; Yuki Suzuki; Akiyo Nakano; Yoshihiko Ogawa; Shinsuke Yonekawa; Shiro Endo; Fumiko Mizuno; Kei Kasahara; Keiichi Mikasa; Mitsuo Kaku; Hisakazu Yano
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

4.  Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.

Authors:  Qingwen He; Weiyuan Chen; Liya Huang; Qili Lin; Jingling Zhang; Rui Liu; Bin Li
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-06-21       Impact factor: 3.944

5.  The emergence of carbapenem resistant Klebsiella pneumoniae in Malaysia: correlation between microbiological trends with host characteristics and clinical factors.

Authors:  Ye-Mun Low; Polly Soo-Xi Yap; Kartini Abdul Jabar; Sasheela Ponnampalavanar; Rina Karunakaran; Rukumani Velayuthan; Chun-Wie Chong; Sazaly Abu Bakar; Mohd Yasim Md Yusof; Cindy Shuan-Ju Teh
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-07       Impact factor: 4.887

6.  The Novel CarbaLux Test for Carbapenemases and Carbapenem Deactivating AmpC Beta-Lactamases.

Authors:  Hans Rudolf Pfaendler; Hans-Ulrich Schmidt; Heike Freidank
Journal:  Front Microbiol       Date:  2020-11-23       Impact factor: 5.640

7.  Rampant spread of infection in an afebrile immune-competent patient presenting with young-onset ischaemic stroke.

Authors:  Umang Arora; Animesh Ray; Surabhi Vyas; Naval Kishore Vikram
Journal:  BMJ Case Rep       Date:  2020-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.